CoChat

Modeling and Predicting Tumor Response in Radioligand Therapy

Open access
Kletting, Peter, Thieme, Anne, Eberhardt, Nina, Rinscheid, Andreas, D’Alessandria, Calogero, Allmann, Jakob, Wester, Hans-Jürgen, Tauber, Robert, Beer, Ambros J., Glatting, Gerhard, Eiber, Matthias · 2019 · Journal of Nuclear Medicine
Cited by 67

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The aim of this work was to develop a theranostic method that allows prediction of prostate-specific membrane antigen (PSMA)–positive tumor volume after radioligand therapy (RLT) based on a pretherapeutic PET/CT measurement and physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) modeling at the example of RLT using 177Lu-labeled PSMA for imaging and therapy (PSMA I&T). Methods: A recently developed PBPK model for 177Lu-PSMA I&T RLT was extended to account for tumor (exponential) growth and reduction due to irradiation (linear quadratic model). Data from 13 patients with metastatic castration-resistant prostate cancer were retrospectively analyzed. Pharmacokinetic/pharmacodynamic parameters were simultaneously fitted in a Bayesian framework to PET/CT activity concentrations, planar scintigraphy data, and tumor volumes before and after (6 wk) therapy. The method was validated using the leave-one-out Jackknife method. The tumor volume after therapy was predicted on the basis of pretherapy PET/CT imaging and PBPK/PD modeling. Results: The relative deviation of the predicted and measured tumor volume for PSMA-positive tumor cells (6 wk after therapy) was 1% ± 40%, excluding 1 patient (prostate-specific antigen–negative) from the population. The radiosensitivity for the prostate-specific antigen–positive patients was determined to be 0.0172 ± 0.0084 Gy−1. Conclusion: To our knowledge, the proposed method is the first attempt to solely use PET/CT and modeling methods to predict the PSMA-positive tumor volume after RLT. Internal validation shows that this is feasible with an acceptable accuracy. Improvement of the method and external validation of the model is ongoing.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2967/jnumed.118.210377

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 67

Metadata

Authors
Kletting, P., Thieme, A., Eberhardt, N., Rinscheid, A., D’Alessandria, C., Allmann, J., Wester, H.-J., Tauber, R., Beer, A. J., Glatting, G., & Eiber, M.
Venue
Journal of Nuclear Medicine
Published
2018-05-10
Volume
60
Issue
1
Pages
65-70
ISSN
  • 0161-5505 (ISSN-L)
  • 2159-662X
OpenAlex
W2800411274
Cited by
67
References
2
FWCI
4.09
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modeling and Predicting Tumor Response in Radioligand Therapy. https://app.cochat.ai/papers/10.2967/jnumed.118.210377
The paper
Kletting, P., Thieme, A., Eberhardt, N., Rinscheid, A., D’Alessandria, C., Allmann, J., Wester, H.-J., Tauber, R., Beer, A. J., Glatting, G., & Eiber, M. (2019). Modeling and Predicting Tumor Response in Radioligand Therapy. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.118.210377

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.